Osocimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Osocimab Usage And Synthesis

Uses

Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects[1].

References

[1] Schaefer M, et al. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI. J Mol Biol. 2019 Dec 6;431(24):4817-4833. DOI:10.1016/j.jmb.2019.09.008

Osocimab(2056878-75-0)Related Product Information

• Research Grade Acazicolcept (DHC83404)
• Tesidolumab
• Rocatinlimab
• Ozoralizumab
• Ubamatamab
• Plonmarlimab
• Apitegromab
• Obiltoxaximab
• Crovalimab
• Sulesomab